Tag: Embozene
Varian announces first participant treated in GENESIS II trial of genicular...
Varian, a Siemens Healthineers company, announced today that the first trial participant has been treated as part of GENESIS II, a study of Embozene...
Varian receives FDA breakthrough device designation for its Embozene microspheres
Varian, a Siemens Healthineers company, today announced that the US Food and Drug Administration (FDA) has granted the company breakthrough device designation for its...
Embozene microspheres are now indicated for prostate artery embolization
Boston Scientific showed at the Global Embolization Cancer Symposium and Technologies (GEST US; 17–19 May, Miami Beach, USA) meeting that the US Food and...
